Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile
Dr. Nina Niu Sanford

@niusanford

GI Radiation Oncologist | Boston, @Princeton, @harvardmed, now @UTSWNews in Dallas | buying in bulk | @AAAS IF/THEN | Tweets=own | FCOI: rb.gy/h

ID: 1064888789200527361

linkhttps://utswmed.org/doctors/nina-sanford/ calendar_today20-11-2018 14:30:46

4,4K Tweet

8,8K Followers

1,1K Following

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Wow, the center advertising proton radiotherapy for osteoarthritis cites 1 study in support of their strategy…and it is your paper using photons!! 🥴

Wow, the center advertising proton radiotherapy for osteoarthritis cites 1 study in support of their strategy…and it is your paper using photons!! 🥴
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Nice discussion. I think Matt Spraker is referring to MGH data here – initially was mixed proton/photon due to scheduling (protons only available 4 days/week), also mixed improved skin sparing and conformality using IMRT. With PBS, treatment was 100% protons but that came later.

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Clarification re: chemo since some folks have asked. Patients can get initial 4-6 months chemo (prior to enrollment) at outside hospital. Also, once randomized, chemo during chemoRT (either on control arm or with 25 fx dose-escalated RT) can also be given at outside hospital.

NRG Oncology (@nrgonc) 's Twitter Profile Photo

We recently activated NRG-GI011, also known as LAP100, a Phase III randomized controlled trial will assess the role of dose-escalated radiotherapy (target biologic effective dose of 100 Gy, hence LAP100) in locally advanced pancreatic cancer. ow.ly/zxSe50WqbCT Dr. Nina Niu Sanford

We recently activated NRG-GI011, also known as LAP100, a Phase III randomized controlled trial will assess the role of dose-escalated radiotherapy (target biologic effective dose of 100 Gy, hence LAP100) in locally advanced pancreatic cancer. ow.ly/zxSe50WqbCT <a href="/NiuSanford/">Dr. Nina Niu Sanford</a>
Diaza Ariyanto (@diazaoa) 's Twitter Profile Photo

Genuine thank you to Dr. Nina Niu Sanford who has been willing to be a speaker in this morning/evening for Indonesian Radiation Oncology Society!!! Even though it's 2 a.m. in UK, it was really good to hear insights on ASCO 2025 updates. Hopefully this will not be a one time thing!

Genuine thank you to <a href="/NiuSanford/">Dr. Nina Niu Sanford</a> who has been willing to be a speaker in this morning/evening for Indonesian Radiation Oncology Society!!!

Even though it's 2 a.m. in UK, it was really good to hear insights on ASCO 2025 updates.

Hopefully this will not be a one time thing!
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

This is a pet peeve of mine as well. Patient goes for 2nd opinion, & suddenly all scans going forward *need* to be done at that institution (even if not getting treatment there). Leads to more pt travel, & logistical hurdles for treating team in getting images transferred, etc.

Bijoy Telivala (@bijoytelivala) 's Twitter Profile Photo

Dr. Nina Niu Sanford So common Reasons given Our radiologists are much better We have a higher Tesla mri or thinner slice CT Reasons not explained More cost More inconvenience More money for the ivory tower with facility fee

Thor Halfdanarson (@oncothor) 's Twitter Profile Photo

I am not aware of any better speakers on the topic of GI radiation oncology than Krishan Jethwa. Everything just becomes crystal clear. This is why you want to attend Mayo Clinic Comprehensive Cancer Center CME courses in heme/onc. Quality updates for practitioners. Mayo Clinic Hematology-Oncology Fellowship

I am not aware of any better speakers on the topic of GI radiation oncology than <a href="/KrishanJethwa/">Krishan Jethwa</a>. Everything just becomes crystal clear. This is why you want to attend <a href="/MayoCancerCare/">Mayo Clinic Comprehensive Cancer Center</a> CME courses in heme/onc. Quality updates for practitioners. <a href="/MayoHemeOnc/">Mayo Clinic Hematology-Oncology Fellowship</a>